De novo HLA antibodies after blood transfusion and/or kidney transplant in children with kidney disease
Open Access
- 20 February 2026
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (7) , 2157-2167
Abstract
Background This study assessed de novo human leukocyte antigen (HLA) antibodies associated with blood transfusions in a paediatric kidney transplantation cohort, associated risk factors and outcomes. Methods Patients with kidney disease at Royal Children’s Hospital (Melbourne, Australia) who were transfused and/or received a kidney transplant between 2000 and 2018 were included. HLA antibody results from pre- and post-transfusion serum specimens, blood donor typing (where available) and clinical and laboratory data were collected. A control group comprised non-transfused patients from the same cohort. The primary outcome was the incidence proportion of de novo blood donor specific HLA antibodies (bDSA). Secondary outcomes included risk factors, including eplet mismatches with the blood donor, kidney donor and both. Results Screening identified 123 transfused and 63 non-transfused patients, with 34 and 28, respectively, included. Transfused patients were younger. At mean fluorescence intensity (MFI) cutoff 500, 36.7% of transfused patients developed de novo HLA class 1 bDSA and 23.3% de novo HLA class 2 bDSA. Overall, de novo HLA class 1 and class 2 antibodies were non-significantly higher in the transfused group (64.7%/55.9%) than in the non-transfused group (46.4% for both, p = 0.200 and p = 0.610, respectively). Risk factors identified included younger age (p < 0.05) and rhesus factor D (RhD) negative status (p = 0.021). The number of shared eplet mismatches was associated with corresponding de novo HLA antibodies (p = 0.02). Conclusions Blood transfusion can be associated with bDSA in paediatric kidney disease, especially with shared blood and kidney donor mismatches. Strategies to avoid sensitisation, such as HLA selection of blood donors, may reduce this risk. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary informationKeywords
Funding Information
- National Blood Authority
- Royal Children's Hospital
This publication has 26 references indexed in Scilit:
- Human leukocyte antigen sensitization from red cell transfusions: Rate and risk factors in renal and nonrenal patients requiring transfusionAmerican Journal of Transplantation, 2025
- Transfusion-specific alloimmune responses following blood transfusion pre–kidney transplantationAmerican Journal of Transplantation, 2024
- Transfusion-induced HLA sensitization in wait-list patients and kidney transplant recipientsKidney International, 2024
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Prevalence and predictors of blood transfusion after pediatric kidney transplantationPediatric Nephrology, 2018
- HLA sensitisation: can it be prevented?Pediatric Nephrology, 2014
- Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft lossTransplant Immunology, 2013
- Long-term neurocognitive outcomes of patients with end-stage renal disease during infancyPediatric Nephrology, 2013
- CKiD (CKD in Children) Prospective Cohort Study: A Review of Current FindingsAmerican Journal of Kidney Diseases, 2012
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009